Clinical trial
FROG-ARDS: Correlation of IL-17A to Hyperinflammatory Biomarkers, Sub-phenotype, and Clinical Outcomes in Patients With Acute Respiratory Distress Syndrome in the FROG ICU Dataset
NCT06779942 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- FROG-ARDS: Correlation of IL-17A to Hyperinflammatory Biomarkers, Sub-phenotype, and Clinical Outcomes in Patients With Acute Respiratory Distress Syndrome in the FROG ICU Dataset
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 15, 2024
- Completion date
- December 31, 2024
- Enrollment
- 414 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acute respiratory distress syndrome (ards), acute respiratory failure (arf)